111 Capital acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 4,582 shares of the company’s stock, valued at approximately $589,000. A number of other hedge funds and other institutional investors have also bought and sold shares of the company. […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Emerald Investment Advisers LLC Takes $3.55 Million Position in Merck KGaA $MKGAF | 0 | 11.47 | 23-08-2026 |
| 2 | Bank of New York Mellon Corp Takes Position in Martin Marietta Materials, Inc. $MLM | 0 | 8.62 | 23-08-2026 |
| 3 | Danske Bank A S Makes New $727,000 Investment in Mercury Systems Inc $MRCY | 0 | 9.88 | 23-08-2026 |
| 4 | Deutsche Bank AG Acquires New Position in NNN REIT, Inc. $NNN | 0 | 11.14 | 23-08-2026 |
| 5 | 11,365 Shares in Cardinal Health, Inc. $CAH Acquired by Callan Family Office LLC | 0 | 10.82 | 23-08-2026 |
| 6 | Bank of New York Mellon Corp Takes Position in Archer Daniels Midland Company $ADM | 0 | 8.62 | 23-08-2026 |
| 7 | Callan Family Office LLC Takes Position in Aramark $ARMK | 0 | 11.32 | 23-08-2026 |
| 8 | 2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal | 0 | 7 | 25-06-2026 |
| 9 | Eli Lilly and Company $LLY Stake Boosted by Sax Wealth Advisors LLC | 0 | 10.85 | 10-08-2026 |